相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alum: an old dog with new tricks
Yumei Wen et al.
EMERGING MICROBES & INFECTIONS (2016)
New generation adjuvants - From empiricism to rational design
Derek T. O'Hagan et al.
VACCINE (2015)
Application of Systems Vaccinology to Evaluate Inflammation and Reactogenicity of Adjuvanted Preventative Vaccines
David J. M. Lewis et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients
Neil L. Berinstein et al.
ONCOIMMUNOLOGY (2015)
Vaccine Adjuvants: from 1920 to 2015 and Beyond
Alberta Di Pasquale et al.
VACCINES (2015)
Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein
Bert Schepens et al.
EMBO MOLECULAR MEDICINE (2014)
Designing and building the next generation of improved vaccine adjuvants
Luis A. Brito et al.
JOURNAL OF CONTROLLED RELEASE (2014)
IgG-Mediated Anaphylaxis to a Synthetic Long Peptide Vaccine Containing a B Cell Epitope Can Be Avoided by Slow-Release Formulation
Esther D. Quakkelaar et al.
JOURNAL OF IMMUNOLOGY (2014)
Immunogenicity/Hypersensitivity of Biologics
Michael W. Leach et al.
TOXICOLOGIC PATHOLOGY (2014)
Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRI
Kimberly D. Brewer et al.
VACCINE (2014)
Canadian Adjuvant Initiative Workshop, March 26-27, 2013-Ottawa, Canada
Lakshmi Krishnan et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Modern Subunit Vaccines: Development, Components, and Research Opportunities
Peter Michael Moyle et al.
CHEMMEDCHEM (2013)
Key roles of adjuvants in modern vaccines
Steven G. Reed et al.
NATURE MEDICINE (2013)
Accelerating Next-Generation Vaccine Development for Global Disease Prevention
Wayne C. Koff et al.
SCIENCE (2013)
Antigen depot is not required for alum adjuvanticity
Sharon Hutchison et al.
FASEB JOURNAL (2012)
First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients
Neil L. Berinstein et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Study designs for the nonclinical safety testing of new vaccine products
Roy Forster
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2012)
Trends in vaccine adjuvants
Virgil E. J. C. Schijns et al.
EXPERT REVIEW OF VACCINES (2011)
Identification of markers that distinguish IgE- from IgG-mediated anaphylaxis
Marat V. Khodoun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Novel Breast/Ovarian Cancer Peptide Vaccine Platform That Promotes Specific Type-1 but not Treg/Tr1-type Responses
Mohan Karkada et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Efficacy of a single close hepatitis B depot vaccine
Lisa D. MacDonald et al.
VACCINE (2010)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
Cutting edge: Inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3
Hanfen Li et al.
JOURNAL OF IMMUNOLOGY (2008)
Mechanisms underlying adverse reactions to vaccines
C.-A. Siegrist
JOURNAL OF COMPARATIVE PATHOLOGY (2007)
Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies
FR Brennan et al.
VACCINE (2005)
分享论文
